Oxidant mechanisms in toxic acute renal failure

American Journal of Kidney Diseases

Volumn 29, Issue 3, 1997, Pages 465-477

  Baliga, Radhakrishna ^b   Ueda, Norishi ^b   Walker, Patrick D ^b   Shah, Sudhir V ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

acute renal failure; cyclosporine A; free radicals; gentamicin; Reactive oxygen metabolites; rhabdomyolysis

Indexed keywords

BENZOIC ACID; BLEOMYCIN; CHELATING AGENT; CIMETIDINE; CYCLOSPORIN A; CYTOCHROME P450; DEFEROXAMINE; DIMETHYL SULFOXIDE; DIMETHYLTHIOUREA; GENTAMICIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCEROL; HEME OXYGENASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MESSENGER RNA; MYOGLOBIN; OXIDIZING AGENT; RANITIDINE; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DOSE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IRON CHELATION; KIDNEY CORTEX; LIPID PEROXIDATION; MITOCHONDRION; NEPHROTOXICITY; NONHUMAN; RAT; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031055848     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90212-2     Document Type: Article

References (57)

1. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-163, 1985
2. Fantone JC, Ward PA: Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 107:397-418, 1982
3. Weiss SJ: Oxygen, ischemia and inflammation. Acta Physiol Scand 126:9-37, 1986 (suppl 548)
4. Baud L, Ardaillou R: Reactive oxygen species: Production and role in the kidney. Am J Physiol 251:F765-F776, 1986
5. Freeman BA, Crapo JD: Free radicals and tissue injury. Lab Invest 47:412-426, 1982
6. Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 186:1-85, 1990
7. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D: Oxygen radicals and human disease. Ann Intern Med 107:526-545, 1987
8. McCord JM, Fridovich I: The biology and pathology of oxygen radicals. Ann Intern Med 89:122-127, 1978
9. Fridovich I: The biology of oxygen radicals. The superoxide radical is an agent of oxygen toxicity; Superoxide dismutases provide an important defense. Science 201:875-880, 1978
10. Lampert MB, Weiss SJ: The chlorinating potential of the human monocyte. Blood 62:645-651, 1983
11. Klebanoff SJ: Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 93:480-489, 1980
12. Weiss SJ, LoBuglio AF: Phagocyte-generated oxygen metabolites and cellular injury. Lab Invest 47:5-18, 1982
13. Weiss SJ, Lampert MB, Test ST: Long-lived oxidants generated by human neutrophils: Characterization and bioactivity. Science 222:625-628, 1983
14. McCord JM, Fridovich I: Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055, 1969
15. McCord JM: Free radicals and inflammation: Protection of synovial fluid by Superoxide dismutase. Science 185:529-531, 1974
16. Humes HD, Weinberg JM: Toxic nephropathies, in Brenner BM, Rector FC Jr (eds): The Kidney, vol 2. Philadelphia, PA, Saunders, 1986, pp 1491-1532
17. Walker PD, Shah SV: Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria. Am J Physiol 253:C495-C499, 1987
18. Yang CL, Du XH, Han YX: Renal cortical mitochondria are the source of oxygen free radicals enhanced by gentamicin. Ren Fail 17:21-26, 1995
19. Guidet BR, Shah SV: In vivo generation of hydrogen peroxide by rat kidney cortex and glomeruli. Am J Physiol 256:F158-F164, 1989
20. Margoliash E, Novogrodsky A, Schejter A: Irreversible reaction of 3-amino-1:2:4-triazole and related inhibitors with the protein of catalase. Biochem J 74:339-348, 1960
21. Tephly TR, Mannering GJ, Parks RE Jr: Studies on the mechanism of inhibition of liver and erythrocyte catalase activity by 3-amino-1,2,4-triazole (AT). J Pharmacol Exp Ther 134:77-82, 1961
22. 2 production by brain in vivo. J Appl Physiol 63:353-358, 1987
23. Ueda N, Guidet B, Shah SV: Gentamicin-induced mobilization of iron from renal cortical mitochondria. Am J Physiol 265:F435-F439, 1993
24. Priuska EM, Schacht J: Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol 50:1749-1752, 1995
25. Walker PD, Shah SV: Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest 81:334-341, 1988
26. Nakajima T, Hishida A, Kato A: Mechanisms for protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats. Am J Physiol 266:F425-F431, 1994
27. Ramsammy LS, Josepovitz C, Ling KY, Lane BP, Kaloyanides GJ: Effects of diphenyl-phenylenediamine on gentamicin-induced lipid peroxidation and toxicity in rat renal cortex. J Pharmacol Exp Ther 238:83-88, 1986
28. Ademuyiwa O, Ngaha EO, Ubah FO: Vitamin E and selenium in gentamicin nephrotoxicity. Hum Exp Toxicol 9:281-288, 1990
29. Kays SE, Crowell WA, Johnson MA: Iron supplementation increases gentamicin nephrotoxicity in rats. J Nutr 121:1869-1875, 1991
30. Ben Ismail TH, Ali BH, Bashir AA: Influence of iron, deferoxamine and ascorbic acid on gentamicin-induced nephrotoxicity in rats. Gen Pharmacol 25:1249-1252, 1994
31. Bywaters EGL, Beall D: Crush injuries with impairment of renal function. BMJ 1:427-432, 1941
32. Gabow PA, Kaehny WD, Kelleher SP: The spectrum of rhabdomyolysis. Medicine 61:141-152, 1982
33. Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M: Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med 291:807-811, 1974
34. Koffler A, Friedler RM, Massry SG: Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med 85:23-28, 1976
35. Hostetter TH, Wilkes BM, Brenner BM: Renal circulatory and nephron function in experimental acute renal failure, in Brenner BM, Lazarus JM (eds): Acute Renal Failure, vol 1. Philadelphia, PA, Saunders, 1983, pp 99-115
36. 2 generation by rat kidney in glycerol-induced renal failure. Am J Physiol 257:F440-F445, 1989
37. Zager RA: Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49:314-326, 1996
38. Zager RA: Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria. Kidney Int 49:741-751, 1996
39. Salahudeen AK, Clark EC, Nath KA: Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. J Clin Invest 88:1886-1893, 1991
40. Bunton CA: Oxidation of α-diketones and α-ketoacids by hydrogen peroxide. Nature 163:444, 1949
41. Halestrap AP, Scott RD, Thomas AP: Mitochondrial pyruvate transport and its hormonal regulation. Int J Biochem 11:97-105, 1980
42. Murer H, Burckhardt G: Membrane transport of anions across epithelia of mammalian small intestine and kidney proximal tubule. Rev Physiol Biochem Pharmacol 96:1-51, 1983
43. Shah SV, Walker PD: Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol 255:F438-F443, 1988
44. Paller MS: Hemoglobin- and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity. Am J Physiol 255:F539-F544, 1988
45. Zager RA: Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest 90:711-719, 1992
46. Orrenius S, Ellin A, Jakobsson SV, Thor H, Cinti DL, Schenkman JB, Estabrook RW: The cytochrome P-450-containing mono-oxygenase system of rat kidney cortex microsomes. Drug Metab Dispos 1:350-357, 1973
47. Bysani GK, Kennedy TP, Ky N, Rao NV, Blaze CA, Hoidal JR: Role of cytochrome P-450 in reperfusion injury of the rabbit lung. J Clin Invest 86:1434-1441, 1990
48. Paller MS, Jacob HS: Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci U S A 91:7002-7006, 1994
49. Baliga R, Zhang Z, Baliga M, Shah SV: Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 49:362-369, 1996
50. Meister A: Selective modification of glutathione metabolism. Science 220:472-477, 1983
51. Meister A: New developments in glutathione metabolism and their potential application in therapy. Hepatology 4:739-742, 1984
52. Meister A, Anderson ME, Hwang O: Intracellular cysteine and glutathione delivery systems. J Am Coll Nutr 5:137-151, 1986
53. Olson CE: Glutathione modulates toxic oxygen metabolite injury of canine chief cell monolayers in primary culture. Am J Physiol 254:G49-G56, 1988
54. Dethmers JK, Meister A: Glutathione export by human lymphoid cells: Depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc Natl Acad Sci U S A 78:7492-7496, 1981
55. Arrick BA, Nathan CF, Griffith OW, Cohn ZA: Glutathione depletion sensitizes tumor cells to oxidative cytolysis. J Biol Chem 257:1231-1237, 1982
56. Andreoli SP, Mallett CP, Bergstein JM: Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury. J Lab Clin Med 108:190-198, 1986
57. Doroshow JH, Locker GY, Ifrim I, Myers CE: Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest 68:1053-1064, 1981